What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Retina
His primary areas of investigation include Retinal, Cis-trans-Isomerases, Genetic enhancement, Retina and Ophthalmology.
Particularly relevant to Retinitis pigmentosa is his body of work in Retinal.
Cis-trans-Isomerases is connected with RPE65 and Disease in his research.
Albert M. Maguire has included themes like Leber's congenital amaurosis, Gene therapy of the human retina and Vector in his RPE65 study.
His study in Retina is interdisciplinary in nature, drawing from both Genetics and Molecular biology.
The study incorporates disciplines such as Optometry, Clinical trial and Surgery in addition to Ophthalmology.
His most cited work include:
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis (1728 citations)
- Gene therapy restores vision in a canine model of childhood blindness. (1025 citations)
- Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial (654 citations)
What are the main themes of his work throughout his whole career to date?
Albert M. Maguire mainly investigates Ophthalmology, Retinal, Genetic enhancement, Retina and Visual acuity.
His study on Ophthalmology is mostly dedicated to connecting different topics, such as Surgery.
His specific area of interest is Retinal, where Albert M. Maguire studies RPE65.
His Genetic enhancement research integrates issues from Retinal degeneration, Adeno-associated virus, Transgene, Immunology and Viral vector.
His studies deal with areas such as Pathology, Anatomy and Cell biology as well as Retina.
Albert M. Maguire has researched Visual acuity in several fields, including Visual field, Clinical trial and Randomized controlled trial.
He most often published in these fields:
- Ophthalmology (43.80%)
- Retinal (31.75%)
- Genetic enhancement (25.18%)
What were the highlights of his more recent work (between 2017-2021)?
- Ophthalmology (43.80%)
- Retinal (31.75%)
- RPE65 (19.34%)
In recent papers he was focusing on the following fields of study:
Albert M. Maguire mostly deals with Ophthalmology, Retinal, RPE65, Genetic enhancement and Visual acuity.
The Retinal study combines topics in areas such as Orientation, Visual dysfunction and Retina.
His RPE65 study combines topics in areas such as Heterozygote advantage, Mutation, Disease, Pathology and Retinal dystrophy.
His work carried out in the field of Genetic enhancement brings together such families of science as Retinal structure, Adeno-associated virus, Bioinformatics, Compound heterozygosity and Anti vegf.
His biological study spans a wide range of topics, including Retinal degeneration and Visual field.
His Vitrectomy study integrates concerns from other disciplines, such as Leber's congenital amaurosis, Adverse effect, Nyctalopia and Gene mutation.
Between 2017 and 2021, his most popular works were:
- Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. (74 citations)
- Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. (74 citations)
- Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (43 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Retina
His main research concerns Retinal, Ophthalmology, Genetic enhancement, RPE65 and Visual acuity.
The various areas that he examines in his Retinal study include Confocal and Retina.
His research in Ophthalmology intersects with topics in Randomized controlled trial and Physical examination.
The Genetic enhancement study which covers Adeno-associated virus that intersects with Cilium, Immune system, Pathology and Ciliopathy.
His work carried out in the field of RPE65 brings together such families of science as Antibody, Disease, Allele and Bioinformatics.
His Visual acuity research incorporates themes from Young adult, Adverse effect and Clinical trial, Phases of clinical research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
